CN Patent

CN112424231B — 抗pd-1抗体及其剂量和用途

Assigned to Tayu Huaxia Biotech Medical Group Co ltd · Expires 2022-09-13 · 4y expired

What this patent protects

本申请提供了抗PD‑1抗体或其片段。还提供了使用该抗体或其片段治疗和诊断诸如癌症、感染或免疫紊乱的疾病的方法。

USPTO Abstract

本申请提供了抗PD‑1抗体或其片段。还提供了使用该抗体或其片段治疗和诊断诸如癌症、感染或免疫紊乱的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112424231B
Jurisdiction
CN
Classification
—
Expires
2022-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Tayu Huaxia Biotech Medical Group Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.